These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1119 related articles for article (PubMed ID: 36034698)

  • 1. Curcumin-driven reprogramming of the gut microbiota and metabolome ameliorates motor deficits and neuroinflammation in a mouse model of Parkinson's disease.
    Cui C; Han Y; Li H; Yu H; Zhang B; Li G
    Front Cell Infect Microbiol; 2022; 12():887407. PubMed ID: 36034698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The protective role of microbiota in the prevention of MPTP/P-induced Parkinson's disease by resveratrol.
    Tao J; An Y; Xu L; Wang Y; Wang C; Li P; Li M; Yan D; Wang M; Zhong G; Wu M
    Food Funct; 2023 May; 14(10):4647-4661. PubMed ID: 37102320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rubusoside mitigates neuroinflammation and cellular apoptosis in Parkinson's disease, and alters gut microbiota and metabolite composition.
    Meng T; Zhang Y; Huang J; Pandey V; Fu S; Ma S
    Phytomedicine; 2024 Feb; 124():155309. PubMed ID: 38237261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Coffee against MPTP-Induced Motor Deficits and Neurodegeneration in Mice Via Regulating Gut Microbiota.
    Liu J; Zhang Y; Ye T; Yu Q; Yu J; Yuan S; Gao X; Wan X; Zhang R; Han W; Zhang Y
    J Agric Food Chem; 2022 Jan; 70(1):184-195. PubMed ID: 35016506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine Induced Parkinson's Disease in Mouse: Potential Association between Neurotransmitter Disturbance and Gut Microbiota Dysbiosis.
    Zhu Y; Huan F; Wang J; Xie X; Yu G; Wang X; Jiang L; Gao R; Xiao H; Ding H; Wang J
    ACS Chem Neurosci; 2020 Oct; 11(20):3366-3376. PubMed ID: 32926778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-acetyl-L-leucine protects MPTP-treated Parkinson's disease mouse models by suppressing Desulfobacterota via the gut-brain axis.
    Xu Z; Lian C; Pan L; Lai W; Zhang F; Peng L; Zhou S; Zhao G; Yang X; Zhang G; Tan Z; Wang Y
    Brain Res Bull; 2023 Oct; 202():110729. PubMed ID: 37579888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Low-Protein, High-Carbohydrate Diet Exerts a Neuroprotective Effect on Mice with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-Induced Parkinson's Disease by Regulating the Microbiota-Metabolite-Brain Axis and Fibroblast Growth Factor 21.
    Chu C; Li T; Yu L; Li Y; Li M; Guo M; Zhao J; Zhai Q; Tian F; Chen W
    J Agric Food Chem; 2023 Jun; 71(23):8877-8893. PubMed ID: 37267589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The intestinal microbiota exerts a sex-specific influence on neuroinflammation in a Parkinson's disease mouse model.
    Zhou X; Gao Y; Wei J; Luo J; Wang Y; Yue M; Wang B; Hong D; Chen T; Fang X
    Neurochem Int; 2024 Feb; 173():105661. PubMed ID: 38157887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intestinal Pathology and Gut Microbiota Alterations in a Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) Mouse Model of Parkinson's Disease.
    Lai F; Jiang R; Xie W; Liu X; Tang Y; Xiao H; Gao J; Jia Y; Bai Q
    Neurochem Res; 2018 Oct; 43(10):1986-1999. PubMed ID: 30171422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroprotective Effects of Sodium Butyrate by Restoring Gut Microbiota and Inhibiting TLR4 Signaling in Mice with MPTP-Induced Parkinson's Disease.
    Guo TT; Zhang Z; Sun Y; Zhu RY; Wang FX; Ma LJ; Jiang L; Liu HD
    Nutrients; 2023 Feb; 15(4):. PubMed ID: 36839287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibroblast growth factor 21 ameliorates behavior deficits in Parkinson's disease mouse model via modulating gut microbiota and metabolic homeostasis.
    Yang C; Wang W; Deng P; Wang X; Zhu L; Zhao L; Li C; Gao H
    CNS Neurosci Ther; 2023 Dec; 29(12):3815-3828. PubMed ID: 37334756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroprotective Effects of Bifidobacterium animalis subsp. lactis NJ241 in a Mouse Model of Parkinson's Disease: Implications for Gut Microbiota and PGC-1α.
    Dong Y; Qi Y; Chen J; Han S; Su W; Ma X; Yu Y; Wang Y
    Mol Neurobiol; 2024 Oct; 61(10):7534-7548. PubMed ID: 38409641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fecal microbiota transplantation protects rotenone-induced Parkinson's disease mice via suppressing inflammation mediated by the lipopolysaccharide-TLR4 signaling pathway through the microbiota-gut-brain axis.
    Zhao Z; Ning J; Bao XQ; Shang M; Ma J; Li G; Zhang D
    Microbiome; 2021 Nov; 9(1):226. PubMed ID: 34784980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Curcumin alleviates 1-methyl- 4-phenyl- 1,2,3,6-tetrahydropyridine- induced Parkinson's disease in mice via modulating gut microbiota and short-chain fatty acids.
    Cai B; Zhong L; Wang Q; Xu W; Li X; Chen T
    Front Pharmacol; 2023; 14():1198335. PubMed ID: 37388445
    [No Abstract]   [Full Text] [Related]  

  • 15. Probiotic Clostridium butyricum ameliorated motor deficits in a mouse model of Parkinson's disease via gut microbiota-GLP-1 pathway.
    Sun J; Li H; Jin Y; Yu J; Mao S; Su KP; Ling Z; Liu J
    Brain Behav Immun; 2021 Jan; 91():703-715. PubMed ID: 33148438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A neurotherapeutic approach with Lacticaseibacillus rhamnosus E9 on gut microbiota and intestinal barrier in MPTP-induced mouse model of Parkinson's disease.
    Aktas B; Aslim B; Ozdemir DA
    Sci Rep; 2024 Jul; 14(1):15460. PubMed ID: 38965287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroprotective effects of fecal microbiota transplantation on MPTP-induced Parkinson's disease mice: Gut microbiota, glial reaction and TLR4/TNF-α signaling pathway.
    Sun MF; Zhu YL; Zhou ZL; Jia XB; Xu YD; Yang Q; Cui C; Shen YQ
    Brain Behav Immun; 2018 May; 70():48-60. PubMed ID: 29471030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vancomycin Pretreatment on MPTP-Induced Parkinson's Disease Mice Exerts Neuroprotection by Suppressing Inflammation Both in Brain and Gut.
    Cui C; Hong H; Shi Y; Zhou Y; Qiao CM; Zhao WJ; Zhao LP; Wu J; Quan W; Niu GY; Wu YB; Li CS; Cheng L; Hong Y; Shen YQ
    J Neuroimmune Pharmacol; 2023 Jun; 18(1-2):72-89. PubMed ID: 35091889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gut microbiota-derived propionate mediates the neuroprotective effect of osteocalcin in a mouse model of Parkinson's disease.
    Hou YF; Shan C; Zhuang SY; Zhuang QQ; Ghosh A; Zhu KC; Kong XK; Wang SM; Gong YL; Yang YY; Tao B; Sun LH; Zhao HY; Guo XZ; Wang WQ; Ning G; Gu YY; Li ST; Liu JM
    Microbiome; 2021 Jan; 9(1):34. PubMed ID: 33517890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 5-HT4 Receptor is Protective for MPTP-induced Parkinson's Disease Mice Via Altering Gastrointestinal Motility or Gut Microbiota.
    Cui C; Shi Y; Hong H; Zhou Y; Qiao C; Zhao L; Jia X; Zhao W; Shen Y
    J Neuroimmune Pharmacol; 2023 Dec; 18(4):610-627. PubMed ID: 37782386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 56.